A Crowd-sourced BiotechDueDiligence Journal Watch

What happens when you combine two of the most popular features here at BiotechDueDiligence - Tweets of the Week and Journal Watch? You get a Twitter-sourced collection of intriguing and noteworthy articles from scientific and medical journals. I've been meaning to try this for awhile, so let me know what you think!

Our survey of P hacking (eg overanalysis to get p<0.05) led by Megan Head is out http://t.co/z5WSNHBkBz @LukeHolman_Evo @RobLanfear

— Michael Jennions (@Mikejennions) March 13, 2015

. @UCSF Team Identifies Why Disease Thickens Mucus in #CysticFibrosis https://t.co/C5g5Z2tSmw http://t.co/7QpOFNNRGs pic.twitter.com/V3fhAqmIZR

— Andy Biotech (@AndyBiotech) March 8, 2015

.@RNAiAnalyst's Article on RNAi in Science: http://t.co/go3ITCGUo0 pic.twitter.com/OeW4oWVTfB

— Dan Marks (@Festivus159) March 5, 2015

Editorial: Preventing Peanut Allergy through Early Consumption — Ready for Prime Time? #AAAAI15 http://t.co/hie0M5YlNm

— NEJM (@NEJM) February 23, 2015

not to be outdone in the world of #openaccess publishing, the superb @JExpMed gives us a Cancer immunity special http://t.co/rFSKVed20e

— Paul D. Rennert (@PDRennert) February 10, 2015

$MRK CETPi Anacetrapib Ph3 REALIZE data for #HeFH in @TheLancet http://t.co/LNDOFpHf5z Editorial http://t.co/U2k3xoBeaG $AEGR $AMGN $REGN

— Andy Biotech (@AndyBiotech) March 3, 2015

Final one h/t @chasingthealpha

Comparison of Drug Approvals in Europe Versus the United States: An Analysis of Discrepancies Between Drug Products Reviewed by EMA and FDA
Makuch and Shi. Therapeutic Innovation and Regulatory Science.